Citations

Mayo Clinic

Showing 10 of 108572 citations.

Conjunctival Biopsy of a Patient With Mpox
Tran, Meagan , Gonzalez, Valeria , Patel, Dharmendra , Shusko, Alexander , McCullough, Ann E. , Shah, Ami, McCullough, Ann, Gonzalez, Valeria V , Shah, Ami A. , Patel, Dharmendra

JAMA Ophthalmology | January 11, 2024 | Volume: 142 | Issue: 2 | Pages: 157

10.1001/jamaophthalmol.2023.5780 | PMID 38206632 Get It

This case report describes a conjunctival biopsy of a patient with mpox infection.
Managing Chronic Constipation in Women
Bering, Jamie , Vegunta, Suneela , Abraham, Neena S.

Journal of Women's Health | January 11, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1089/jwh.2023.0692 | PMID 38207235 Get It

Guiding principles for the conduct of the Violence Study of Healthcare Workers and System (ViSHWaS): Insights from a global survey
Amal, Tanya , Bhatt, Gaurang , Faisal, Umme Habiba , Rais, Mohammed Amir , Najam, Nadia , Banga, Akshat , Khalid, Aisha , Surani, Salim , Nawaz, Faisal A. , Kashyap, Rahul

Journal of Global Health | January 11, 2024 | Volume: 14 | Issue: No issue available | Pages: No page available

10.7189/jogh.14.04008 | PMID 38206325 Get It

Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans
Kottom, Theodore J. , Carmona, Eva M. , Limper, Andrew H. , Carmona, Eva M , Limper, Andrew H , Kottom, Theodore J

Antimicrobial Agents and Chemotherapy | January 11, 2024 | Volume: 68 | Issue: 2 | Pages: No page available

10.1128/aac.00811-23 | PMID 38206037 Get It

ABSTRACT Pneumocystis jirovecii, the fungus that causes Pneumocystis jirovecii pneumonia (PJP), is a leading cause of morbidity and mortality in immunocompromised individuals. We have previously shown that lung epithelial cells can bind Pneumocystis spp. β-glucans via the EphA2 receptor, resulting in activation and release of proinflammatory cytokines. Herein, we show that in vivo Pneumocystis spp. β-glucans activation of the inflammatory signaling cascade in macrophages can be pharmacodynamically inhibited with the EphA2 receptor small-molecule inhibitor ALW-II-41-27. In vitro , when ALW-II-41-27 is administrated via intraperitoneal to mice prior to the administration of highly proinflammatory Saccharomyces cerevisiae β-glucans in the lung, a significant reduction in TNF-alpha release was noted in the ALW-II-41-27 pre-treated group. Taken together, our data suggest that targeting host lung macrophage activation via EphA2 receptor-fungal β-glucans interactions with ALW-II-41-27 or other EphA2 receptor kinase targeting inhibitors might be an attractive and viable strategy to reduce detrimental lung inflammation associated with PJP.
Does embedding pediatric eating disorder treatment in primary care bridge the access gap?
Billings, Marcie, Mattke, Angela, Partain, Paige , O’Brien, Janna Gewirtz, Narr, Cassandra, Breland, Renee, Loeb, Katharine L. , Sim, Leslie , Lebow, Jocelyn , Jacobson, Robert M. , Lebow, Jocelyn , O’Brien, Janna R. Gewirtz

Eating Disorders | January 11, 2024 | Volume: 32 | Issue: 3 | Pages: 283-296

10.1080/10640266.2023.2299592 | PMID 38206038 Get It

A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients
Ames, Steven C. , Lange, Lori , Ames, Gretchen E. , White, Launia J. , Foran, James M. , Foran, James M , Heckman, Michael G. , Roy, Vivek

Cancer Medicine | January 11, 2024 | Volume: 13 | Issue: 3 | Pages: No page available

10.1002/cam4.6906 | PMID 38205943 Get It

AbstractAimThe aim of study was to investigate whether depression and anxiety symptoms and illness perception prior to hematopoietic stem cell transplantation (HSCT) predict health related quality of life (HRQOL) at Day 100 and 1 year following HSCT.MethodsA total of 205 patients who underwent HSCT (N = 127 autologous transplants, N = 78 allogeneic transplants) were included in this prospective study. Baseline assessment was assessed prior to transplantation and post HSCT data were collected at Day 100 and 1 year. At baseline we assessed depressive symptoms (Patient Health Questionnaire‐9), anxiety symptoms (Generalized Anxiety Disorder‐7), illness perception (Brief Illness Perception Questionnaire), and HRQOL (Functional Assessment of Cancer Therapy‐BMT).ResultsPatients who expressed a greater level of concern about the severity, course, and ability to exert control over one's illness (i.e., illness perception) and who reported a greater level of depression and anxiety symptoms prior to HSCT reported lower HRQOL at both Day 100 and 1 year posttransplant, with a similar degree of association observed at the two follow‐up time points.ConclusionsOur findings suggest that pretransplant perceptions about their illness and negative mood are significant predictors of HRQOL following HSCT. Illness perception, depression, and anxiety are potentially modifiable risk factors for less than optimal outcome after HCSCT and intervention strategies should be explored.
Importance of Diversity, Equity, and Inclusion in the Hepatopancreatobiliary Workforce
Rengers, Timothy A. , Warner, Susanne G.

Cancers | January 11, 2024 | Volume: 16 | Issue: 2 | Pages: 326

10.3390/cancers16020326 | PMID 38254815 Get It

Diversity is a catalyst for progress that prevents institutional stagnation and, by extension, averts descent to mediocrity. This review focuses on the available data concerning hepatopancreatobiliary (HPB) surgical workforce demographics and identifies evidence-based strategies that may enhance justice, equity, diversity, and inclusion for HPB surgeons and their patients. We report that the current United States HPB surgical workforce does not reflect the population it serves. We review data describing disparity-perpetuating hurdles confronting physicians from minority groups underrepresented in medicine at each stage of training. We further examine evidence showing widespread racial and socioeconomic disparities in HPB surgical care and review the effects of workforce diversity and physician–patient demographic concordance on healthcare outcomes. Evidence-based mitigators of structural racism and segregation are reviewed, including tailored interventions that can address social determinants of health toward the achievement of true excellence in HPB surgical care. Lastly, select evidence-based data driving surgical workforce solutions are reviewed, including intentional compensation plans, mentorship, and sponsorship.
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma
Bischoff, Lindsay , Fugazzola, Laura , Buczek, Erin , Haugen, Bryan R. , McIver, Bryan, McMullen, Caitlin , Newbold, Kate, Rocke, Daniel J. , Russell, Marika D. , Ryder, Mabel , Sherman, Eric J. , Shindo, Maisie L., Stack, Brendan C. , Wirth, Lori J. , Randolph, Gregory W. , Ryder, Mabel , Ganly, Ian , Faquin, William C , Sadow, Peter M. , Shonka, David C. , Singer, Michael C. , Wong, Richard J. , Randolph, Gregory William

JAMA Otolaryngology–Head & Neck Surgery | January 11, 2024 | Volume: 150 | Issue: 3 | Pages: 265

10.1001/jamaoto.2023.4323 | PMID 38206595 Get It

Importance Oncocytic (Hürthle cell) thyroid carcinoma is a follicular cell-derived neoplasm that accounts for approximately 5% of all thyroid cancers. Until recently, it was categorized as a follicular thyroid carcinoma, and its management was standardized with that of other differentiated thyroid carcinomas. In 2022, given an improved understanding of the unique molecular profile and clinical behavior of oncocytic thyroid carcinoma, the World Health Organization reclassified oncocytic thyroid carcinoma as distinct from follicular thyroid carcinoma. The International Thyroid Oncology Group and the American Head and Neck Society then collaborated to review the existing evidence on oncocytic thyroid carcinoma, from diagnosis through clinical management and follow-up surveillance. Observations Given that oncocytic thyroid carcinoma was previously classified as a subtype of follicular thyroid carcinoma, it was clinically studied in that context. However, due to its low prevalence and previous classification schema, there are few studies that have specifically evaluated oncocytic thyroid carcinoma. Recent data indicate that oncocytic thyroid carcinoma is a distinct class of malignant thyroid tumor with a group of distinct genetic alterations and clinicopathologic features. Oncocytic thyroid carcinoma displays higher rates of somatic gene variants and genomic chromosomal loss of heterozygosity than do other thyroid cancers, and it harbors unique mitochondrial DNA variations. Clinically, oncocytic thyroid carcinoma is more likely to have locoregional (lymph node) metastases than is follicular thyroid carcinoma—with which it was formerly classified—and it develops distant metastases more frequently than papillary thyroid carcinoma. In addition, oncocytic thyroid carcinoma rarely absorbs radioiodine. Conclusions and Relevance The findings of this review suggest that the distinct clinical presentation of oncocytic thyroid carcinoma, including its metastatic behavior and its reduced avidity to radioiodine therapy, warrants a tailored disease management approach. The reclassification of oncocytic thyroid carcinoma by the World Health Organization is an important milestone toward developing a specific and comprehensive clinical management for oncocytic thyroid carcinoma that considers its distinct characteristics.
Pathophysiology of Facial Nerve Stimulation and Its Implications for Electrical Stimulation in Cochlear Implants
Saoji, Aniket A. , DeJong, Melissa D., Bertsch, Natasha J., Graham, Madison K., Goulson, Kayla R., Pease, Megan L. Wernsman, Gruenwald, Jill M., Bross, Abigail E., Dornhoffer, James R. , Neff, Brian A., Driscoll, Colin L. W., Carlson, Matthew L. , Lane, John I. , Pesch, Joerg, Vanpoucke, Filiep J.

Otology & Neurotology | January 11, 2024 | Volume: 45 | Issue: 2 | Pages: e84-e90

10.1097/mao.0000000000004082 | PMID 38206062 Get It

Objectives A small number of cochlear implant (CI) users experience facial nerve stimulation (FNS), which can manifest as facial twitching. In some patients, this can be resolved by adjusting the electrical stimulation parameters. However, for others, facial stimulation can significantly impair CI outcomes or even prevent its use. The exact mechanisms underlying FNS are unclear and may vary among patients. Design Transimpedance measurements were used to assess lateral and longitudinal spread of current within 15 cochlea of nucleus CI recipients with FNS (13 unilateral recipients and 1 bilateral recipient). We compared the transimpedance measurements with programming parameters from clinical visits and pre- and postoperative temporal bone computed tomography (CT) scans to identify factors that may contribute to FNS in each CI ear. Results In nine ears, transimpedance curves showed inflection, which suggests a localized current sink within the cochlea. This indicates a low-impedance pathway through which current exits the cochlea and stimulates the labyrinthine segment of the facial nerve canal. Electrodes near this current sink were disabled or underfit to minimize facial stimulation. In the other seven ears, current flow peaked toward the basal end of the cochlea, suggesting that current exits through the round window or other structures near the basal end of the cochlea, stimulating the tympanic segment of the facial nerve. Conclusions Objective transimpedance measurements can be used to elucidate the mechanisms of FNS and to develop strategies for optimizing electrical stimulation parameters and speech coding to minimize or eliminate FNS in a small subset of CI users.
Systematic Review of Auditory Training Outcomes in Adult Cochlear Implant Recipients and Meta-Analysis of Outcomes
Dornhoffer, James R. , Chidarala, Shreya , Patel, Terral , Khandalavala, Karl R. , Nguyen, Shaun A. , Schvartz‐Leyzac, Kara C. , Dubno, Judy R. , Carlson, Matthew L. , Moberly, Aaron C. , Moberly, Aaron C , McRackan, Theodore R.

Journal of Clinical Medicine | January 11, 2024 | Volume: 13 | Issue: 2 | Pages: 400

10.3390/jcm13020400 | PMID 38256533 Get It

Objective: to review evidence on the efficacy of auditory training in adult cochlear implant recipients. Data Sources: PRISMA guidelines for a systematic review of the literature were followed. PubMed, Scopus, and CINAHL databases were queried on 29 June 2023 for terms involving cochlear implantation and auditory training. Studies were limited to the English language and adult patient populations. Study Selection: Three authors independently reviewed publications for inclusion in the review based on a priori inclusion and exclusion criteria. Inclusion criteria encompassed adult cochlear implant populations, an analysis of clinician- or patient-directed auditory training, and an analysis of one or more measures of speech recognition and/or patient-reported outcome. Exclusion criteria included studies with only pediatric implant populations, music or localization training in isolation, and single-sample case studies. Data Extraction: The data were collected regarding study design, patient population, auditory training modality, auditory training timing, speech outcomes, and data on the durability of outcomes. A quality assessment of the literature was performed using a quality metric adapted from the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) Working Group guidelines. Data Synthesis and Meta-Analysis: Data were qualitatively summarized for 23 studies. All but four studies demonstrated significant improvement in at least one measured or patient-reported outcome measure with training. For 11 studies with sufficient data reporting, pre-intervention and post-intervention pooled means of different outcome measures were compared for 132 patients using meta-analysis. Patient-direct training was associated with significant improvement in vowel-phoneme recognition and speech recognition in noise (p < 0.05 and p < 0.001, respectively), and clinician-directed training showed significant improvement in sentence recognition in noise (p < 0.001). Conclusions: The literature on auditory training for adult cochlear implant recipients is limited and heterogeneous, including a small number of studies with limited levels of evidence and external validity. However, the current evidence suggests that auditory training can improve speech recognition in adult cochlear implant recipients.